Main pathway: VEGFR2 and angiogenesis The best-characterized pharmacological cascade of BPC-157 involves the VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) receptor
He goes, okay, I'll put you to the test
Abbreviations ABCG2: ATP-binding cassette subfamily G, member 2 AMPK: AMP-activated protein kinase BCRP: Breast cancer resistance protein CXCL-1: Chemokine (C-X-C motif) ligand 1 eNOS: Endothelial nitric oxide synthase ERK: Extracellular signal-regulated kinase GLUT9: Glucose transporter 9 GSIS: Glucose-stimulated insulin secretion IL-6: Interleukin-6 MCP-1: Monocyte chemoattractant protein-1 NCX mito : mitochondrial sodium-calcium exchanger NF-B: Nuclear factor kappa B nNOS: Neural nitric oxide synthase NO: Nitric oxide NOS: Nitric oxide synthase ROS: Reactive oxygen species SLC: Solute carrier family SSPG: Steady-state plasma glucose T2DM: Type 2 diabetes mellitus URAT1: Urate transporter 1 References Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al
Cycle Length: 48 weeks
Biochemical and histological analyses were performed on the hippocampal and cortical tissue, assessing oxidative stress markers, antioxidant enzyme activity, and glial activation through spectrophotometric assays and immunohistochemistry